Sarcopenia
Welcome,         Profile    Billing    Logout  
 46 Companies   12 Products   12 Products   17 Mechanisms of Action   756 Trials   22406 News 


«12...3940414243444546474849...401402»
  • ||||||||||  Review, Journal:  Post-Radiotherapy Dysphagia in Head and Neck Cancer: Current Management by Speech-Language Pathologists. (Pubmed Central) -  Jul 3, 2024   
    There is wide variation in treatment programmes, with a paucity of evidence to support optimal type, timing and intensity of treatment. We discuss the need for further research, including exploration of the impact of radiotherapy on the central nervous system (CNS), the link between sarcopenia and radiotherapy-induced dysphagia and the benefits of visual biofeedback in rehabilitation.
  • ||||||||||  Journal:  Kidney function and sarcopenia: A risk assessment. Author's reply. (Pubmed Central) -  Jul 2, 2024   
    This review explores the mechanisms, assessment, and clinical impact of malnutrition, emphasizing the importance of nutritional support in gastric cancer patients undergoing gastrectomy. No abstract available
  • ||||||||||  Journal:  Quantitative 3D-CT imaging of sarcopenia mitigation in elderly: evidence from a case report. (Pubmed Central) -  Jul 1, 2024   
    Despite aging, the results of the scans performed at the beginning and end of the study period did not show significant changes in the patient's musculature, suggesting that a persistent Full-Body in-Bed Gym protocol ("Gym Bed" exercise routine) can effectively contribute to maintaining muscle mass and density in the elderly. These preliminary results highlight the potential of advanced imaging techniques not only to diagnose but also to quantify the effectiveness of non-pharmacological interventions against sarcopenia.
  • ||||||||||  Journal:  Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both. (Pubmed Central) -  Jul 1, 2024   
    Future studies are needed to reach a consensus and reduce diagnostic variation. With similar pathophysiology and shared risk factors between the two diseases, future research may also identify potential therapeutic targets along the liver-muscle axis that would benefit both sarcopenia and MASLD in order to maximize their outcomes.
  • ||||||||||  Review, Journal:  Nexus Between Sarcopenia and Microbiome Research: A Bibliometric Exploration. (Pubmed Central) -  Jul 1, 2024   
    Malnutrition, dietary fiber, signaling pathways, frailty, and intestinal microbes are currently research hotspots. Furthermore, the visual atlas analysis of research on microbes and sarcopenia helps to track the knowledge structure in research fields related to sarcopenia and microbes, providing direction for future research.
  • ||||||||||  Review, Journal:  Sarcopenic obesity in patients awaiting liver transplant: Unique challenges for nutritional recommendations. (Pubmed Central) -  Jul 1, 2024   
    While these nutrition guidelines have been established in non-cirrhotic patients, established guidelines for liver transplant candidates with sarcopenic obesity are lacking. In this paper, we review existing literature on sarcopenic obesity in patients with chronic liver disease and address opportunities to improve nutritional counseling in patients awaiting liver transplantation.
  • ||||||||||  Review, Journal:  Role of Nutrition in the Management of Patients with Chronic Musculoskeletal Pain. (Pubmed Central) -  Jul 1, 2024   
    Beyond mere analgesia, comprehensive patient care for CMP requires acknowledgment of the complex and multifactorial nature of pain and its foundational elements. Embracing an integrative treatment model allows healthcare practitioners to promise better patient prognoses, enriched life quality, and a decrease in the sustained healthcare costs associated with CMP.
  • ||||||||||  Review, Journal:  Geriatric syndromes: the importance of the problem, controversial issues of terminology. (Pubmed Central) -  Jun 30, 2024   
    The main purpose of the presented review is precisely to try to answer these questions. In addition, it has not yet been determined whether geriatric syndromes should be included in the diagnosis (the only exception is sarcopenia syndrome, which was officially included in the 10th International Classification of Diseases in 2016).
  • ||||||||||  Trial completion date, Trial primary completion date:  ENHANce: Exercise and Nutrition for Healthy AgeiNg (clinicaltrials.gov) -  Jun 28, 2024   
    P=N/A,  N=180, Recruiting, 
    Pre-NAC SO was an independent prognostic factor in patients with LAGC undergoing NAC; post-NAC SO independently predicted postoperative morbidity. Trial completion date: Jun 2024 --> Jun 2025 | Trial primary completion date: Dec 2023 --> Dec 2024
  • ||||||||||  Biomarker, Review, Journal:  Biomarkers of Cellular Senescence and Aging: Current State-of-the-Art, Challenges and Future Perspectives. (Pubmed Central) -  Jun 27, 2024   
    Further, technologies from the current decade including multi-omics and computational methods used in the fields of senescence and aging are also discussed in this review. Understanding aging-associated biological processes by using cellular senescence biomarkers can enable therapeutic innovation and interventions to improve the quality of life of older adults.